CN100577219C - A kind of pectin/polyvinyl alcohol hydrogel material and preparation method thereof - Google Patents
A kind of pectin/polyvinyl alcohol hydrogel material and preparation method thereof Download PDFInfo
- Publication number
- CN100577219C CN100577219C CN200710028603A CN200710028603A CN100577219C CN 100577219 C CN100577219 C CN 100577219C CN 200710028603 A CN200710028603 A CN 200710028603A CN 200710028603 A CN200710028603 A CN 200710028603A CN 100577219 C CN100577219 C CN 100577219C
- Authority
- CN
- China
- Prior art keywords
- pectin
- polyvinyl alcohol
- preparation
- alcohol hydrogel
- swelling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004372 Polyvinyl alcohol Substances 0.000 title claims abstract description 69
- 229920002451 polyvinyl alcohol Polymers 0.000 title claims abstract description 69
- 229920001277 pectin Polymers 0.000 title claims abstract description 64
- 239000001814 pectin Substances 0.000 title claims abstract description 64
- 235000010987 pectin Nutrition 0.000 title claims abstract description 64
- 239000000017 hydrogel Substances 0.000 title claims abstract description 53
- 239000000463 material Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 230000008961 swelling Effects 0.000 claims abstract description 26
- 238000010438 heat treatment Methods 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000018044 dehydration Effects 0.000 claims abstract description 11
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 11
- 238000010257 thawing Methods 0.000 claims abstract description 5
- 230000008014 freezing Effects 0.000 claims abstract description 4
- 238000007710 freezing Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 230000010355 oscillation Effects 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 claims description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000006136 alcoholysis reaction Methods 0.000 claims description 2
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 208000008035 Back Pain Diseases 0.000 abstract description 4
- 208000008930 Low Back Pain Diseases 0.000 abstract description 4
- 210000000845 cartilage Anatomy 0.000 abstract description 4
- 206010061246 Intervertebral disc degeneration Diseases 0.000 abstract description 3
- 206010033425 Pain in extremity Diseases 0.000 abstract description 3
- 208000018180 degenerative disc disease Diseases 0.000 abstract description 3
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 abstract description 3
- 208000035965 Postoperative Complications Diseases 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 7
- 238000002513 implantation Methods 0.000 description 5
- 238000011068 loading method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000012925 biological evaluation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000002607 Pseudarthrosis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- -1 acyl phosphorus oxide Chemical compound 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 229910001392 phosphorus oxide Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种果胶/聚乙烯醇水凝胶材料及其制备方法,其如下组分和重量百分数组成:果胶1~10%,聚乙烯醇1~50%。优选的比例为果胶3~7%,聚乙烯醇20~30%,余量为水。其制备方法包括溶胀,加热,冻融和脱水。本发明的果胶/聚乙烯醇水凝胶的生物安全性较好,溶胀性能、溶胀平衡时的粘弹力学特性均适合于人体,可以制造出适合人体的果胶/聚乙烯醇水凝胶人工髓核假体,广泛用于治疗腰椎间盘退变所致的腰腿痛患者,替代髓核的生理功能,降低椎体塌陷、假体下沉等术后并发症,改善患者术后生活质量。还可以作为其他支架材料,用于替代、修复颈椎间盘髓核、软骨等组织。
The invention discloses a pectin/polyvinyl alcohol hydrogel material and a preparation method thereof, which comprises the following components and weight percentages: 1-10% of pectin and 1-50% of polyvinyl alcohol. The preferred ratio is 3-7% of pectin, 20-30% of polyvinyl alcohol, and the balance is water. Its preparation method includes swelling, heating, freezing and thawing and dehydration. The pectin/polyvinyl alcohol hydrogel of the present invention has good biological safety, and the swelling performance and viscoelastic properties at the time of swelling balance are all suitable for the human body, and the pectin/polyvinyl alcohol hydrogel suitable for the human body can be produced Artificial nucleus pulposus prosthesis is widely used to treat patients with low back and leg pain caused by lumbar disc degeneration, replaces the physiological function of the nucleus pulposus, reduces postoperative complications such as vertebral body collapse and prosthesis subsidence, and improves the quality of life of patients after surgery . It can also be used as other scaffold materials to replace and repair cervical disc nucleus pulposus, cartilage and other tissues.
Description
技术领域 technical field
本发明涉及医用仿生材料技术领域,具体的说,涉及一种果胶/聚乙烯醇水凝胶材料及其制备方法。The invention relates to the technical field of medical bionic materials, in particular to a pectin/polyvinyl alcohol hydrogel material and a preparation method thereof.
背景技术 Background technique
无论是经典的腰椎间盘摘除术,还是脊柱融合术,都改变了腰段脊柱正常的生理形态和生物力学环境,加剧椎间盘退变;为解决上述问题,非融合技术应运而生,其主要优点是理论上降低了邻近节段退变、避免了假关节的形成。其中,人工髓核(Prosthetic Disc Nucleus,PDN)被认为是可以替代脊柱融合术,成为治疗腰椎间盘退变所致下腰痛或腰腿痛的有效方法之一。自1996年在德国首次开展PDN髓核假体置换(Ray CD.The PDN prosthetic disc-nucleus device.Eur Spine J.2002S2:S137-42.),到目前全世界已突破4600例。患者术后腰椎ODI(Oswestry Disability Index)评分从52.2%降到13.4%,椎间隙高度平均增加19.5%;中期(4年)随访发现腰椎活动度明显优于单纯髓核摘除者,但是假体下沉达到49.2%、软骨终板损伤达60.0%。Both the classic lumbar discectomy and spinal fusion have changed the normal physiological shape and biomechanical environment of the lumbar spine and aggravated the degeneration of the intervertebral disc; in order to solve the above problems, non-fusion technology came into being, its main advantages are Theoretically, it reduces the degeneration of adjacent segments and avoids the formation of pseudarthrosis. Among them, artificial nucleus pulposus (Prosthetic Disc Nucleus, PDN) is considered to be an alternative to spinal fusion, and has become one of the effective methods for treating low back pain or lumbago and leg pain caused by lumbar disc degeneration. Since the first PDN nucleus pulposus replacement in Germany in 1996 (Ray CD. The PDN prosthetic disc-nucleus device. Eur Spine J. 2002S2: S137-42.), up to now there have been more than 4600 cases worldwide. The postoperative lumbar ODI (Oswestry Disability Index) score of the patient dropped from 52.2% to 13.4%, and the intervertebral space height increased by an average of 19.5%. The mid-term (4-year) follow-up found that the lumbar spine activity was significantly better than that of the simple nucleus pulposus removal, but the prosthesis Shen reached 49.2%, and cartilage endplate damage reached 60.0%.
目前成形髓核假体所用水凝胶材料有:聚乙烯醇(USP 5047055.09/10/1991,USP 6280475.08/28/2001),聚丙烯酰胺与聚丙腈、聚氨基甲酸酯共混物(USP 4772287.09/20/1988.)。原位注射型髓核假体所用材料有:聚丙烯酰胺聚乙二醇丙烯酸酯、二甲替丙烯酰胺(需加入酰基氧化磷作为光引发剂,CN 1561185A,01/05/2005.),硅橡胶(CNZL95243809.708/07/1996.),蛋白水凝胶(BioDisc公司)。At present, the hydrogel materials used for forming nucleus pulposus prosthesis are: polyvinyl alcohol (USP 5047055.09/10/1991, USP 6280475.08/28/2001), polyacrylamide, polyacrylonitrile, polyurethane blend (USP 4772287.09 /20/1988.). The materials used for in situ injection type nucleus pulposus prosthesis are: polyacrylamide polyethylene glycol acrylate, dimethyl acrylamide (need to add acyl phosphorus oxide as photoinitiator, CN 1561185A, 01/05/2005.), silicon Rubber (CNZL95243809.708/07/1996.), protein hydrogel (BioDisc company).
聚乙烯醇水凝胶有以下特点:(1)生物相容性与其它疏水的弹性体及金属相比,更接近于人体髓核。(2)压缩强度高,可承受较大载荷并能恢复椎间高度。(3)水和水溶性物质是可渗透的。(4)在脱水后可再水合而不改变材料的性质。但是成形髓核假体所用聚乙烯醇水凝胶在溶涨平衡时的弹性模量,为3Mpa(吴靖平,陈统一,陈中伟,等。聚乙烯醇水凝胶髓核的生物力学特性,复旦学报(医学版),2004,31(1):55~58)或4Mpa以上(USP 6280475.08/28/2001),显著大于仰卧静息位椎间盘内的压力0.1MPa、也大于弯腰负重时的2.3MPa(Willke HJ,Neef P,Caimi,M,et al.New in vivo measurements ofpressures in the intervertebral disc in daily life.Spine,1999,24(8):755~62.),导致髓核假体刚度过大,是导致软骨终板骨折、塌陷的原因之一,因此需降低所用水凝胶的弹性模量。Polyvinyl alcohol hydrogel has the following characteristics: (1) Biocompatibility is closer to the human nucleus pulposus than other hydrophobic elastomers and metals. (2) High compressive strength, can withstand large loads and restore intervertebral height. (3) Water and water-soluble substances are permeable. (4) Can be rehydrated after dehydration without changing the properties of the material. However, the elastic modulus of the polyvinyl alcohol hydrogel used in the formation of the nucleus pulposus prosthesis is 3Mpa (Wu Jingping, Chen Tongyi, Chen Zhongwei, etc. Biomechanical properties of the polyvinyl alcohol hydrogel nucleus pulposus, Fudan Journal (Medical Edition), 2004, 31(1): 55-58) or above 4Mpa (USP 6280475.08/28/2001), which is significantly greater than the pressure in the intervertebral disc in the supine resting position of 0.1MPa, and also greater than 2.3MPa when bending over to bear weight (Willke HJ, Neef P, Caimi, M, et al. New in vivo measurements of pressures in the intervertebral disc in daily life. Spine, 1999, 24(8): 755~62.), resulting in excessive rigidity of the nucleus pulposus prosthesis , is one of the causes of cartilage endplate fracture and collapse, so it is necessary to reduce the elastic modulus of the hydrogel used.
发明内容 Contents of the invention
本发明的目的在于克服现有髓核所用水凝胶存在的不足,提供一种弹性模量适合于替代腰椎间盘髓核的果胶/聚乙烯醇水凝胶材料。The purpose of the present invention is to overcome the shortcomings of the hydrogel used in the existing nucleus pulposus, and provide a pectin/polyvinyl alcohol hydrogel material whose elastic modulus is suitable for replacing the nucleus pulposus of the lumbar intervertebral disc.
本发明的另一个目的是提供上述果胶/聚乙烯醇水凝胶材料的制备方法。Another object of the present invention is to provide a preparation method of the above-mentioned pectin/polyvinyl alcohol hydrogel material.
为了实现上述目的,本发明在在聚乙烯醇水凝胶研究的基础上,选用另一种也具有亲水特性、相对较软的材料与聚乙烯醇有机结合,制备果胶/聚乙烯醇水凝胶材料。本发明选用的材料是果胶。In order to achieve the above object, the present invention, on the basis of polyvinyl alcohol hydrogel research, selects another kind of material that also has hydrophilic properties and is relatively soft to organically combine with polyvinyl alcohol to prepare pectin/polyvinyl alcohol hydrogel. gel material. The material selected in the present invention is pectin.
本发明的果胶/聚乙烯醇水凝胶材料,由如下组分和重量百分数组成:果胶1~10%,聚乙烯醇1~50%。优选的比例为果胶3~7%,聚乙烯醇20~30%,余量为水。The pectin/polyvinyl alcohol hydrogel material of the present invention is composed of the following components and weight percentages: 1-10% of pectin and 1-50% of polyvinyl alcohol. The preferred ratio is 3-7% of pectin, 20-30% of polyvinyl alcohol, and the balance is water.
在自然界中,仙人掌有丰厚的质径、贮存大量的水分,其中起主要作用的是原果胶,其提炼产物为果胶,分子式为[C6H10O7·H2O]n,是一种线性高分子材料,其水凝胶具有膨胀能力和胶体性质。本发明采用的果胶优选药用级果胶,呈灰或白色粉末状,颗粒直径小于315微米;由柑橘皮中提炼而成,其半乳糖醛酸含量60~85%,酯化度50~80%,1%水溶液的pH为3.0~4.0。In nature, cactus has a rich mass diameter and stores a large amount of water. Among them, protopectin plays a major role, and its refined product is pectin. The molecular formula is [C 6 H 10 O 7 ·H 2 O]n, which is A linear polymer material whose hydrogel has swelling ability and colloidal properties. The pectin used in the present invention is preferably pharmaceutical grade pectin, which is gray or white powder, and the particle diameter is less than 315 microns; it is extracted from citrus peels, its galacturonic acid content is 60-85%, and the degree of esterification is 50-80%. 80%, the pH of 1% aqueous solution is 3.0~4.0.
聚乙烯醇为线性高分子,其分子主链含-CH-CH(OH)-基团,分子式为[CH2=CHOH]n。自1924年首次合成以来,聚乙烯醇因其为水溶性高分子聚合物、安全无毒,广泛用作胶粘剂、混悬剂、包衣材料、软膏基质,作为一种药用辅料纳入药典,本发明优选分析纯的聚乙烯醇,乳白色或白色颗粒状,聚合度为1700~4500,以在2400~2500为最佳;醇解度大于95%。Polyvinyl alcohol is a linear polymer, its main chain contains -CH-CH(OH)-groups, and its molecular formula is [CH 2 =CHOH]n. Since it was first synthesized in 1924, polyvinyl alcohol is widely used as an adhesive, suspending agent, coating material, and ointment base because it is a water-soluble polymer, safe and non-toxic, and is included in the Pharmacopoeia as a pharmaceutical excipient. The preferred method of the invention is analytically pure polyvinyl alcohol, milky white or white granular, with a polymerization degree of 1700-4500, preferably 2400-2500; alcoholysis degree greater than 95%.
本发明的果胶/聚乙烯醇水凝胶材料的制备方法,包括如下步骤:The preparation method of pectin/polyvinyl alcohol hydrogel material of the present invention, comprises the steps:
(1)溶胀:将果胶和聚乙烯醇溶于水中,在15~30℃环境下自然溶胀6~24小时;(1) Swelling: Dissolve pectin and polyvinyl alcohol in water, and swell naturally for 6-24 hours at 15-30°C;
考虑果胶、聚乙烯醇均为线性高分子,分子链间的位阻、水分子需要较长的时间才能进入聚合分子间,因而溶胀的时间要求比较长。Considering that pectin and polyvinyl alcohol are both linear polymers, it takes a long time for the steric hindrance between molecular chains and water molecules to enter the polymer molecules, so the swelling time is relatively long.
(2)加热:加热至溶液的粘度超过40~50×10-3Pa.s,去除加热过程中产生的气泡;(2) Heating: Heating until the viscosity of the solution exceeds 40-50×10 -3 Pa.s, and removing the bubbles generated during the heating process;
由于果胶在低浓度下可以溶于冷水,聚乙烯醇的浓度、聚合度均影响其在水中的溶解,故需要加热以促进果胶和聚乙烯醇在水中的溶解。本发明的加热方式优选:常压下加热至90~95℃、高压反应釜中加热至140℃或微波振荡加热。Since pectin can dissolve in cold water at a low concentration, the concentration and degree of polymerization of polyvinyl alcohol affect its dissolution in water, so heating is required to promote the dissolution of pectin and polyvinyl alcohol in water. The heating method of the present invention is preferably: heating to 90-95° C. under normal pressure, heating to 140° C. in a high-pressure reactor, or microwave oscillation heating.
其中,微波振荡加热以低功率、间断微波振荡加热方法为最佳,具体方法如下:将果胶和聚乙烯醇水溶液,选用100~300瓦低功率,共加热25~45分钟,需间断5次以上,以8~12次为宜;经过此过程该混溶液的粘度超过40~50×10-3Pa.s。Among them, microwave oscillation heating with low power and intermittent microwave oscillation heating method is the best, the specific method is as follows: use pectin and polyvinyl alcohol aqueous solution with low power of 100-300 watts, heat for 25-45 minutes in total, and need to be interrupted 5 times Above, preferably 8-12 times; after this process, the viscosity of the mixed solution exceeds 40-50×10 -3 Pa.s.
所述去除气泡的方法优选60~80℃静置1~4h或低速旋转去除。The method for removing air bubbles is preferably standing at 60-80°C for 1-4 hours or rotating at a low speed.
(3)冻融:将加热成熔融状态的果胶/聚乙烯醇水凝胶置于-20℃冷冻12~36h,室温下完全解冻,此为一次“冻融”。为了在分子之间形成物理性氢键的方法,形成网状交联结构,使果胶/聚乙烯醇水凝胶具有适宜替代腰椎间盘髓核的力学性能,需要反复冻融三次以上。(3) Freezing and thawing: the pectin/polyvinyl alcohol hydrogel heated to a molten state was frozen at -20°C for 12 to 36 hours, and completely thawed at room temperature. This was a "freezing and thawing". In order to form a physical hydrogen bond between molecules, form a network cross-linked structure, and make the pectin/polyvinyl alcohol hydrogel have the mechanical properties suitable for replacing the nucleus pulposus of the lumbar intervertebral disc, it is necessary to repeatedly freeze and thaw more than three times.
(4)脱水,即可得到果胶/聚乙烯醇水凝胶材料。完全含水的水凝胶体积较大,不适合植入体内。因为水凝胶具有脱水后可再水合而不改变材料性质的特点,本发明的脱水方法优选:采用纯度大于99.8%的无水酒精,低温真空下,或恒温干燥箱风干。其中,无水酒精的方法,使果胶/聚乙烯醇水凝胶材料均匀脱水,形状均匀缩小、不发生外形改变,是最佳的脱水方法,具体如下:所用无水酒精与假体的体积比应大于1,以2~8倍体积于材料为佳;每8~48h更换1次无水酒精,最佳24h,直至恒重。(4) Dehydration to obtain the pectin/polyvinyl alcohol hydrogel material. Fully hydrated hydrogels are bulky and unsuitable for implantation in the body. Because the hydrogel can be rehydrated after dehydration without changing the properties of the material, the dehydration method of the present invention is preferably: use absolute alcohol with a purity greater than 99.8%, dry under low temperature vacuum, or in a constant temperature drying oven. Among them, the method of anhydrous alcohol is the best dehydration method to make the pectin/polyvinyl alcohol hydrogel material uniformly dehydrated, the shape shrinks uniformly, and the shape does not change. The details are as follows: the volume of the anhydrous alcohol used and the prosthesis The ratio should be greater than 1, preferably 2 to 8 times the volume of the material; the absolute alcohol should be replaced every 8 to 48 hours, preferably 24 hours, until constant weight.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1.本发明的果胶/聚乙烯醇水凝胶的生物安全性较好,根据国家医疗器械生物学评价标准(GB T 16886)评价,其体外细胞毒性不超过1级、体内植入试验无渗液、化脓等反应,适宜体内植入。1. The biosafety of the pectin/polyvinyl alcohol hydrogel of the present invention is better, according to the evaluation of the national medical device biological evaluation standard (GB T 16886), its in vitro cytotoxicity is no more than 1 grade, and the implantation test in vivo has no Exudation, suppuration and other reactions are suitable for implantation in the body.
2.本发明的果胶/聚乙烯醇水凝胶的溶胀性能、溶胀平衡时的粘弹力学特性均适合于人体,这些特性可以有效维持纤维环张力及椎间高度、缓冲载荷、及在循环载荷下促进水及水溶性物质转运;可以制造出适合人体的果胶/聚乙烯醇水凝胶人工髓核假体,广泛用于治疗腰椎间盘退变所致的腰腿痛患者,替代髓核的生理功能,降低椎体塌陷、假体下沉等术后并发症,改善患者术后生活质量。2. The swelling properties of the pectin/polyvinyl alcohol hydrogel of the present invention and the viscoelastic properties during swelling balance are all suitable for the human body. Promote the transport of water and water-soluble substances under load; can manufacture pectin/polyvinyl alcohol hydrogel artificial nucleus pulposus prosthesis suitable for the human body, which is widely used in the treatment of patients with low back and leg pain caused by lumbar disc degeneration, replacing the nucleus pulposus Improve the physiological function of the patient, reduce postoperative complications such as vertebral body collapse and prosthesis subsidence, and improve the quality of life of patients after surgery.
3.本发明的果胶/聚乙烯醇水凝胶因其具有粘弹力学特性、水及水溶性物质可以渗透,还可以作为其他支架材料,用于替代、修复颈椎间盘髓核、软骨等组织。3. The pectin/polyvinyl alcohol hydrogel of the present invention can also be used as other scaffold materials because of its viscoelastic properties, water and water-soluble substances can penetrate, and can be used to replace and repair cervical intervertebral disc nucleus pulposus, cartilage and other tissues .
附图说明 Description of drawings
图1为果胶/聚乙烯醇水凝胶材料的质量溶胀率与体积溶胀率图;Fig. 1 is the mass swelling rate and the volume swelling rate figure of pectin/polyvinyl alcohol hydrogel material;
图2为果胶/聚乙烯醇水凝胶溶胀平衡时的应力-应变曲线图;Fig. 2 is the stress-strain curve figure when pectin/polyvinyl alcohol hydrogel swelling equilibrium;
图3为果胶/聚乙烯醇水凝胶溶胀加载-卸载过程的应变滞后现象图。Figure 3 is a diagram of the strain hysteresis during the pectin/polyvinyl alcohol hydrogel swelling loading-unloading process.
图4为果胶/聚乙烯醇水凝胶溶胀在600N持续加载时的蠕变图;Fig. 4 is the creep diagram when pectin/polyvinyl alcohol hydrogel swelling is continuously loaded at 600N;
图5为果胶/聚乙烯醇水凝胶溶胀在600N持续加载30min后质量随时间的变化图。Figure 5 is a graph showing the change in mass of pectin/polyvinyl alcohol hydrogel swelling with time after continuous loading at 600N for 30 minutes.
具体实施方式 Detailed ways
实施例1:Example 1:
分别称取果胶6.0g、聚乙烯醇1.2g,搅拌均匀,加入16.8g双蒸水,此“果胶:聚乙烯醇:水”的比例为“5%:25%:70%”,共6份。在25℃自然溶胀12小时后,采用低功率、间断微波振荡加热,选用120瓦加热10min后搅拌、间断1min,继续采用120瓦加热10min,搅拌、间断1分钟;以后每加热3min、间断1min,共7次;选取其中1份测试其乌氏粘度值,为50×10-3Pa·s,停止加热。采用1500rpm旋转5min去除气泡,即可放入零下20℃冷冻24h,室温下解冻6h,如此反复4次。Weigh 6.0g of pectin and 1.2g of polyvinyl alcohol respectively, stir evenly, add 16.8g of double distilled water, the ratio of "pectin: polyvinyl alcohol: water" is "5%: 25%: 70%", a total of 6 servings. After natural swelling at 25°C for 12 hours, use low-power, intermittent microwave oscillation heating, use 120 watts to heat for 10 minutes, then stir and stop for 1 minute, continue to use 120 watts to heat for 10 minutes, stir and stop for 1 minute; after that, heat for 3 minutes and stop for 1 minute. A total of 7 times; select one of them to test its Ubbelohde viscosity value, which is 50×10 -3 Pa·s, and stop heating. Spin at 1500rpm for 5 minutes to remove air bubbles, then freeze at minus 20°C for 24 hours, thaw at room temperature for 6 hours, and repeat this 4 times.
分别测量该果胶/聚乙烯醇水凝胶圆柱体的体积,分别向试管中加入23ml~25ml(2倍于试件的体积)99.8%的无水酒精,室温下每24h测量其质量、并更换同体积无水酒精1次,直至24h质量丢失小于20mg,视为脱水至恒重。Measure the volume of the pectin/polyvinyl alcohol hydrogel cylinder respectively, add 23ml~25ml (2 times the volume of the test piece) 99.8% dehydrated alcohol in the test tube, measure its quality every 24h at room temperature, and Replace the same volume of absolute alcohol once until the mass loss is less than 20 mg in 24 hours, and it is considered as dehydration to constant weight.
实施例2Example 2
分别称取果胶4.0g、聚乙烯醇1.0g,搅拌均匀,加入15.0g双蒸水,此“果胶:聚乙烯醇:水”的比例为“5%:20%:75%”,共6份。在25℃自然溶胀12小时后,采用低功率、间断微波振荡加热,选用100瓦加热10min后搅拌、间断1min,继续采用100瓦加热10min,搅拌、间断1分钟;以后每加热4min、间断1min,共6次;选取其中1份测试其乌氏粘度值,为45×10-3Pa·s,停止加热。采用2000rpm旋转5min去除气泡,即可放入零下20℃冷冻24h,室温下解冻6h,如此反复3次。将果胶/聚乙烯醇水凝胶放在50℃恒温干燥箱中风干,定期测量起质量,直至24h质量丢失小于20mg,视为脱水至恒重。Weigh 4.0g of pectin and 1.0g of polyvinyl alcohol, stir well, add 15.0g of double distilled water, the ratio of "pectin: polyvinyl alcohol: water" is "5%: 20%: 75%", a total of 6 servings. After natural swelling at 25°C for 12 hours, use low-power, intermittent microwave oscillation heating, use 100 watts to heat for 10 minutes, then stir and stop for 1 minute, continue to use 100 watts to heat for 10 minutes, stir and stop for 1 minute; after that, heat for 4 minutes and stop for 1 minute. A total of 6 times; select one of them to test its Ubbelohde viscosity value, which is 45×10 -3 Pa·s, and stop heating. Spin at 2000rpm for 5 minutes to remove air bubbles, then freeze at minus 20°C for 24 hours, and thaw at room temperature for 6 hours, repeat this process 3 times. The pectin/polyvinyl alcohol hydrogel was air-dried in a constant temperature drying oven at 50°C, and its mass was measured regularly until the mass loss within 24 hours was less than 20 mg, which was regarded as dehydration to constant weight.
实施例3Example 3
分别称取果胶3.5g、聚乙烯醇0.5g,搅拌均匀,加入8.5g双蒸水,此“果胶:聚乙烯醇:水”的比例为“4%:28%:68%”,共8份。在25℃自然溶胀12小时后,采用常压水浴加热至95℃,选取其中1份测试其乌氏粘度值,为55×10-3Pa·s,停止加热。水浴60℃静置2小时去除气泡,即可放入零下20℃冷冻36h,室温下解冻8h,如此反复4次。将果胶/聚乙烯醇水凝胶材料自试管中拿出,放在零下80℃、5毫托下低温、真空冻干,定期测量起质量,直至24h质量丢失小于20mg,视为脱水至恒重。Weigh 3.5g of pectin and 0.5g of polyvinyl alcohol, stir well, add 8.5g of double distilled water, the ratio of "pectin: polyvinyl alcohol: water" is "4%: 28%: 68%", a total of 8 servings. After natural swelling at 25°C for 12 hours, heat it to 95°C in a normal pressure water bath, select one of them to test its Ubbelohde viscosity value, which is 55×10 -3 Pa·s, and stop heating. Stand in a water bath at 60°C for 2 hours to remove air bubbles, then freeze at minus 20°C for 36 hours, thaw at room temperature for 8 hours, and repeat this 4 times. Take the pectin/polyvinyl alcohol hydrogel material out of the test tube, place it at minus 80°C and 5 millitorr, and freeze-dry it in a vacuum. Measure its mass regularly until the mass loss in 24 hours is less than 20 mg, which is considered as dehydration to a constant temperature. Heavy.
实施例4 性能实验Embodiment 4 Performance experiment
(1)一般物理性能:本发明的果胶/聚乙烯醇水凝胶材料,其完全脱水状态下玻璃化温度低温区为16.9℃~41.3℃、高温区为106.4℃~130.6℃,其在体温37℃可看作是高弹态,形变相对稳定。(1) General physical properties: the pectin/polyvinyl alcohol hydrogel material of the present invention has a glass transition temperature of 16.9°C to 41.3°C in the low temperature zone and 106.4°C to 130.6°C in the high temperature zone under the fully dehydrated state. 37°C can be regarded as a high elastic state, and the deformation is relatively stable.
(2)生物相容性:按照国家医疗器械生物学评价标准(GBT 16886)所要求的方法,行体外细胞毒性及体内植入试验。将本发明专利果胶/聚乙烯醇水凝胶消毒后,在37℃、10%(V/V)小牛血清DMEM培养液中浸泡24h,所得的浸提液与10%(V/V)小牛血清的DMEM培养液各50%(体积比)所得的液体,作为小鼠成纤维细胞(NTCC L929)的培养液,培养2d时的细胞增殖率大于80%、培养4d、7d时的细胞增殖率接近100%,表明细胞毒性不到1级。另将本发明专利果胶/聚乙烯醇水凝胶制成3mmX3mmX(0.5~1)mm的片状、10mmX3mmX3mm的条状材料,消毒后植入SD大鼠的皮下、臀肌内,所有动物均正常存活、伤口一期愈合,于1周、4周取材,发现局部无异常渗液、化脓等反应。以上可表明本发明果胶/聚乙烯醇水凝胶适合植入体内。(2) Biocompatibility: According to the method required by the national medical device biological evaluation standard (GBT 16886), conduct in vitro cytotoxicity and in vivo implantation tests. After the patent pectin/polyvinyl alcohol hydrogel of the present invention is sterilized, it is soaked in 37 ℃, 10% (V/V) calf serum DMEM culture solution for 24h, and the obtained extract is mixed with 10% (V/V) The liquid obtained by 50% (volume ratio) of DMEM culture fluid of calf serum is used as the culture fluid of mouse fibroblasts (NTCC L929). The proliferation rate was close to 100%, indicating less than grade 1 cytotoxicity. In addition, the patented pectin/polyvinyl alcohol hydrogel of the present invention was made into sheets of 3mmX3mmX(0.5~1)mm and strips of 10mmX3mmX3mm, and implanted into the subcutaneous and gluteal muscles of SD rats after disinfection. Survival normally and the wound healed by first intention. Samples were collected at 1 week and 4 weeks, and no abnormal exudate or suppuration was found in the local area. The above shows that the pectin/polyvinyl alcohol hydrogel of the present invention is suitable for implantation in the body.
(3)溶胀性能:将本发明果胶/聚乙烯醇水凝胶脱水至恒重后,制成直径17.0mm、高17.0mm的圆柱体试件,质量为4.3~4.5g。浸泡于37℃生理盐水中,定期测量其质量及尺寸,直至其质量在24h内变化小于50mg,即达到溶胀平衡,以测试其溶胀性能。果胶/聚乙烯醇水凝胶3d的质量溶胀率为140~160%,占溶胀平衡时的70~80%;3d的体积溶胀率为180~210%,占溶胀平衡时的75~85%,如图1所示。(3) Swelling performance: After dehydrating the pectin/polyvinyl alcohol hydrogel of the present invention to a constant weight, a cylindrical specimen with a diameter of 17.0 mm and a height of 17.0 mm is made, with a mass of 4.3-4.5 g. Soak it in 37°C physiological saline, measure its mass and size regularly, until its mass change is less than 50mg within 24 hours, that is, reach the swelling equilibrium, to test its swelling performance. The mass swelling rate of pectin/polyvinyl alcohol hydrogel 3d is 140-160%, accounting for 70-80% of the swelling equilibrium; the volume swelling rate of 3d is 180-210%, accounting for 75-85% of the swelling equilibrium ,As shown in Figure 1.
(4)粘弹力学性能:将溶胀平衡的水凝胶,制作成直径与高度比为1∶1的圆柱体试件,用生理盐水浸泡,室温下放在MTS材料测试仪上,加载速率为5N/s,循环加载5次(最大载荷500N),回零开始加载至600N,持续30min,测试其蠕变性能,实时采集时间、载荷、位移。通过应力-应变曲线计算出果胶/聚乙烯醇水凝胶的弹性模量为1.6~2.4MPa,如图2所示;果胶/聚乙烯醇水凝胶可以吸收循环载荷能量的10~35%,缓冲外部应力,如图3所示;图3中,曲线所围城的图形面积除以上升曲线与横坐标所围城的面积,即为水凝胶试件所吸收的能量比。果胶/聚乙烯醇水凝胶的蠕变在10min后开始趋于平衡,如图4所示。(4) Viscoelastic properties: The hydrogel with swelling balance is made into a cylindrical specimen with a ratio of diameter to height of 1:1, soaked in physiological saline, placed on an MTS material tester at room temperature, and the loading rate is 5N /s,
(5)水及其水溶性物质的可渗透性:果胶/聚乙烯醇水凝胶在持续30分钟加载600N后,减少3.0~10.0%,卸载2h后质量可恢复55~70%,达到加载前质量的98.8~99.5%,如图5所示。(5) Permeability of water and its water-soluble substances: After pectin/polyvinyl alcohol hydrogel is loaded at 600N for 30 minutes, it decreases by 3.0-10.0%, and after unloading for 2 hours, the mass can recover by 55-70%, reaching the loading level. 98.8-99.5% of the former mass, as shown in Figure 5.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710028603A CN100577219C (en) | 2007-06-15 | 2007-06-15 | A kind of pectin/polyvinyl alcohol hydrogel material and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710028603A CN100577219C (en) | 2007-06-15 | 2007-06-15 | A kind of pectin/polyvinyl alcohol hydrogel material and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101108261A CN101108261A (en) | 2008-01-23 |
| CN100577219C true CN100577219C (en) | 2010-01-06 |
Family
ID=39040647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710028603A Expired - Fee Related CN100577219C (en) | 2007-06-15 | 2007-06-15 | A kind of pectin/polyvinyl alcohol hydrogel material and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100577219C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201000879D0 (en) * | 2010-01-20 | 2010-03-10 | Univ Reading The | Improved hydrogel synthesis |
| CN102205145A (en) * | 2011-05-19 | 2011-10-05 | 中国矿业大学 | Bionic cartilage material and preparation process thereof |
| DE102012007307A1 (en) * | 2012-04-13 | 2013-10-17 | Carl Freudenberg Kg | Hydrogelierende fibers and fiber structures |
| EP3125218A4 (en) * | 2014-03-24 | 2017-04-12 | Fujifilm Corporation | Aqueous gel composition for body organ phantom, and body organ phantom |
| CN106474560B (en) * | 2016-11-04 | 2019-08-02 | 暨南大学 | A kind of hydrogel material and the preparation method and application thereof for 3D biometric print |
| CN107412849A (en) * | 2017-07-31 | 2017-12-01 | 赵娜 | A kind of bionic scaffold material of excellent bonding performance and preparation method thereof |
| CN114773623A (en) * | 2022-03-03 | 2022-07-22 | 杭州爱卓科技有限公司 | Use of reversible gel materials as starting materials for the production of medical models |
-
2007
- 2007-06-15 CN CN200710028603A patent/CN100577219C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101108261A (en) | 2008-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100577219C (en) | A kind of pectin/polyvinyl alcohol hydrogel material and preparation method thereof | |
| Zheng et al. | The electrostimulation and scar inhibition effect of chitosan/oxidized hydroxyethyl cellulose/reduced graphene oxide/asiaticoside liposome based hydrogel on peripheral nerve regeneration in vitro | |
| Varma et al. | Injectable carboxymethylcellulose hydrogels for soft tissue filler applications | |
| JP4644374B2 (en) | Poly (propylene fumarate) crosslinked with poly (ethylene glycol) | |
| EP1888135B1 (en) | Methods of making tough hydrogels | |
| KR102541271B1 (en) | Gellan gum hydrogels, preperation, methods and uses thereof | |
| JP4577987B2 (en) | Biphasic injectable composition particularly useful in repair and plastic surgery | |
| Voldřrich et al. | Long‐term experience with poly (glycol monomethacrylate) gel in plastic operations of the nose | |
| CN114569784B (en) | Folium artemisiae argyi extract-loaded hydrogel and preparation method thereof | |
| CN111569148A (en) | Composite hydrogel for promoting bone repair and preparation method and application thereof | |
| Brady et al. | Optimisation of a novel glass-alginate hydrogel for the treatment of intracranial aneurysms | |
| CN113350567A (en) | Biocompatible polymer dressing based on collagen | |
| ZA200208717B (en) | Polyacrylamide hydrogel and its use as an endoprosthesis. | |
| CN103099689A (en) | Preparation method and application of spiral-shaped nucleus pulposus prosthesis for minimally invasive surgery | |
| EP2574350A1 (en) | Medical uses of lyophilized polymeric membranes containing blood derivatives | |
| CN112587726B (en) | Composite hydrogel stent and preparation method and application thereof | |
| CN118059293A (en) | Polyvinyl alcohol double-network hydrogel for wound surface and preparation method and application thereof | |
| He et al. | Robust, superabsorbent and antibacterial polysaccharide-based hybrid-network hydrogels for wound repair | |
| CN114573839A (en) | Preparation method of curcumin-loaded human hair keratin/chitosan hydrogel | |
| Lee et al. | Subcutaneous toxicity of a dual ionically cross-linked atelocollagen and sodium hyaluronate gel: Rat in vivo study for biological safety evaluation of the injectable hydrogel | |
| CN113694260B (en) | Bone cement hydrogel composite material for vertebroplasty and preparation method thereof | |
| JP7205819B2 (en) | biological tissue repair agent | |
| CN113995889A (en) | Preparation method and application of exosome-loaded electrical and chemical signal dual-conduction hydrogel scaffolds | |
| CN113350568A (en) | Biocompatible polymer dressing based on gelatin | |
| Istikharoh et al. | Study on swelling behaviour of HANP/PVA composites with adding PLGA for alveolar ridge preservation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100106 Termination date: 20100615 |